These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4694922)

  • 1. [Stability and dissociation constants of L-dopa and alpha-L-methyldopa].
    Lippold BC; Jaeger I
    Arch Pharm (Weinheim); 1973 Feb; 306(2):106-17. PubMed ID: 4694922
    [No Abstract]   [Full Text] [Related]  

  • 2. A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients.
    Curzon G; Kantamaneni BD; Trigwell J
    Clin Chim Acta; 1972 Mar; 37():335-41. PubMed ID: 5022098
    [No Abstract]   [Full Text] [Related]  

  • 3. A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain.
    Fahn S; Prasad AL; Delesie R
    Anal Biochem; 1972 Apr; 46(2):557-75. PubMed ID: 4337048
    [No Abstract]   [Full Text] [Related]  

  • 4. 3-methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease.
    Sharpless NS; Muenter MD; Tyce GM; Owen CA
    Clin Chim Acta; 1972 Mar; 37():359-69. PubMed ID: 5022100
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pH on the oxidation pathway of alpha-methyldopa catalysed by tyrosinase.
    Serna Rodríguez P; Rodríguez López JN; Tudela J; Varón R; García Cánovas F
    Biochem J; 1990 Dec; 272(2):459-63. PubMed ID: 2125208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of alpha-methyldopa oxidation by tyrosinase.
    Jiménez M; Garcia-Canovas F; Garcia-Carmona F; Tudela J; Iborra JL
    Int J Biochem; 1986; 18(1):39-47. PubMed ID: 3002882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-methyldopa melanin. Synthesis and stabilization in vitro.
    Sassetti RJ; Fudenberg HH
    Biochem Pharmacol; 1971 Jan; 20(1):57-66. PubMed ID: 5570641
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
    Rivera-Calimlim L
    Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of analogs of phenylalanine and tryptophan on kinetics of DOPA decarboxylase in rat brain.
    De Ropp RS; Furst A
    Brain Res; 1966 Oct; 2(4):323-32. PubMed ID: 5298124
    [No Abstract]   [Full Text] [Related]  

  • 10. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 11. Extemporaneous preparation of methyldopa in two syrup vehicles.
    Newton DW; Rogers AG; Becker CH; Torosian G
    Am J Hosp Pharm; 1975 Aug; 32(8):817-21. PubMed ID: 238389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of the combination of L-alpha-methyldopa and dichlorothiazide in the treatment of arterial hypertension].
    BAILA MR; CINTAS JA
    Dia Med; 1962 Dec; 34():2422-4. PubMed ID: 13969004
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ACTION OF ALPHA-METHYLDOPA (AMD) ON EMOTIONAL BEHAVIOR OBJECTIFIED BY "GROUP TOXICITY" PRODUCED BY DL-AMPHETAMINE AND DL-DIHYDROXYPHENYLALANINE IN MICE].
    HALPERN BN; DRUDI-BARACCO C; BESSIRARD D
    C R Seances Soc Biol Fil; 1963 Dec; 157():1421-6. PubMed ID: 14091868
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha-methyldopa: antihypertensive drug with unusual mechanism of action.
    SJOERDSMA A
    Heart Bull; 1963; 12():1-4. PubMed ID: 13977819
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
    [No Abstract]   [Full Text] [Related]  

  • 17. Enantioseparation of dopa and related compounds by cyclodextrin-modified microemulsion electrokinetic chromatography.
    Borst C; Holzgrabe U
    J Chromatogr A; 2008 Sep; 1204(2):191-6. PubMed ID: 18538332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFFECTS OF ALPHA-METHYL DOPA AND DOPA ON THE AMPHETAMINE EXCITATORY RESPONSE IN RESERPINIZED RATS.
    QUINTON RM; HALLIWELL G
    Nature; 1963 Oct; 200():178-9. PubMed ID: 14073041
    [No Abstract]   [Full Text] [Related]  

  • 19. Automated radiometric assays of enzymatic and nonenzymatic oxidation of DOPA in vitro.
    Tran N
    J Lab Clin Med; 1974 Aug; 84(2):287-91. PubMed ID: 4843233
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA].
    SCHAER H; ZIEGLER WH
    Klin Wochenschr; 1962 Sep; 40():959-62. PubMed ID: 13976633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.